Form 4 for AURA Aura Biosciences, Inc.
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-075412 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-20 | 2025-05-16 | AURA | Johnson David Michael | Dir | P - Purchase | $4.90 | +20.0K | 166.2K | +14% | +$98.0K |
| D | 2025-05-20 | 2025-05-16 | AURA | Johnson David Michael | Dir | P - Purchase | — | +5,000 | 5,000 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | P | A | 20,000 | $4.90 | 166,167 | D | — | — | |
| 2 | Derivative | Common Stock Warrants (right to buy) | 2025-05-16 | P | A | 5,000 | — | 5,000 | D | $4.90 · 2025-05-16 to 2030-05-16 | 5,000 Common Stock | (F1) On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering. |